Phase II study of TAS ‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer-Reference-Cited by-同舟云学术

Phase II study of TAS ‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer

Published:2013-04-18 Issue:3 Volume:2 Page:351-359
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Tsao Anne¹,Hui Edwin Pun²,Juergens Rosalyn³,Marur Shanthi³,Huat Tan Eng⁴,Cher Goh Boon⁵,Hong Ruey‐Long⁶,Hong Waun Ki¹⁷,Chan Anthony Tak‐Cheung²

Affiliation:

1. Department of Thoracic and Head and Neck Medical Oncology University of Texas M.D. Anderson Cancer Center Houston Texas

2. Department of Clinical Oncology State Key Laboratory of Oncology in South China Sir YK Pao Cancer Center The Chinese University of Hong Kong Hong Kong

3. Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland

4. National Cancer Center Singapore Singapore

5. National University of Singapore Hospital Singapore

6. National Taiwan University Hospital Taipei Taiwan

7. Division of Cancer Medicine University of Texas M.D. Anderson Cancer Center Houston Texas

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.79

Reference25 articles.

1. Cancer statistics, 2013

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

3. Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

4. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

5. Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma;Cancers;2022-04-11

2. Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma;Oncogenesis;2020-12

3. Transcription and Translation Inhibitors in Cancer Treatment;Frontiers in Chemistry;2020-04-21

4. Nucleoside analogs as a radiosensitizer modulating DNA repair, cell cycle checkpoints, and apoptosis;Nucleosides, Nucleotides & Nucleic Acids;2019-09-27

5. Management of Metastatic Nasopharyngeal Carcinoma;Nasopharyngeal Carcinoma;2019